WEBINAR
Mastering Membrane Proteins in days with mimetic screening
Introduction:
Join Cube Biotech and Nuclera to discover a rapid, scalable workflow for expressing and stabilizing complex membrane proteins. Learn how Cube Biotech’s membrane mimetics combined with Nuclera’s eProtein Discovery™ system enable stable, functional, assay-ready membrane proteins in just 48 hours. This webinar highlights case studies on key drug targets, demonstrating how optimized membrane protein production accelerates structural biology, drug screening, and therapeutic development.
Sign up:
membrane protein high resolution cryo-em msba
Webinar Topics:
- Best practices for screening and selecting membrane mimetics to enhance protein stability, function and yield
- Cell-free workflows for membrane protein production from DNA to functional protein in days
- Case studies on challenging proteins showcasing improved expression, purification and downstream usability, accelerating structural biology and drug discovery
Learning objectives:
- Understand the challenges of membrane protein expression and purification, and why conventional methods often fall short.
- Explore how Cube Biotech’s portfolio of membrane stabilizing products enhance protein stability and folding.
- Learn how the eProtein Discovery™ system enables rapid and automated cell-free expression of membrane proteins, producing functional, assay-ready results in just 48 hours.
- Gain insights from real-world case studies from Cube Biotech and Nuclera, illustrating how this integrated approach accelerates structural and functional analysis for high-value protein targets.
Speakers:
Stephanie Reikine PhD
Andreas Kiessling PhD
About eProtein Discovery
Nuclera's eProtein Discovery™ system combines digital microfluidic droplet automation with cell-free protein synthesis technologies, it empowers protein scientists to identify the best conditions for expressing and purifying proteins of interest within 24 hours, all on a single consumable cartridge.
The system offers a significant advantage over traditional protein expression methods, allowing researchers to save time and resources by simplifying and automating the process. Its ability to handle multiple genes and customizable cell-free blends makes it a valuable tool for protein scientists in academia and the biopharma industry.